Drug profile · INN
paricalcitol
PARICALCITOL
paricalcitol (PARICALCITOL) is a vitamin d receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — paricalcitol
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
paricalcitol (PARICALCITOL) is a vitamin d receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin D receptor agonist
Primary target: Vitamin D3 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is paricalcitol?
paricalcitol (PARICALCITOL) is a vitamin d receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for paricalcitol?
PARICALCITOL is a marketed brand name for paricalcitol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paricalcitol?
paricalcitol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.